Taho Pharmaceuticals Ltd. (TPEX:6467)

Taho Pharmaceuticals Revenue

Taho Pharmaceuticals had revenue of 631.00K TWD in the half year ending December 31, 2025. This brings the company's revenue in the last twelve months to 5.42M, up 80.82% year-over-year. In the year 2025, Taho Pharmaceuticals had annual revenue of 8.41M.

• Revenue (ttm): 5.42M
• Revenue Growth: +80.82%
• P/S Ratio: 1,260.73
• Revenue / Employee: 154.89K
• Employees: 35
• Market Cap: 6.83B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	8.41M	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	1.07M	-5.29M	-83.23%
Dec 31, 2022	6.36M	-6.04M	-48.73%
Dec 31, 2017	12.40M	-23.61M	-65.57%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 17, 2026

Data Sources Report a data error